Genus plc Stock
Price
Target price
€27.80
€27.80
-2.110%
-0.6
-2.110%
-
24.11.25 / Frankfurt
WKN: 762548 / Symbol: GENSF / Name: Genus / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Genus plc Stock
We can see a decrease in the price for Genus plc. Compared to yesterday it has lost -€0.600 (-2.110%).
Pros and Cons of Genus plc in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
B****
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Genus plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Genus plc | -2.110% | 0.000% | -2.740% | 44.898% | 58.659% | -17.919% | -37.747% |
| Ironwood Pharmaceuticals | 0.000% | 1.515% | 94.203% | -18.293% | -36.190% | -75.729% | -73.065% |
| Novocure Ltd | -0.090% | 6.417% | -12.235% | -36.431% | -64.406% | -85.733% | -89.671% |
| Iovance Biotherapeutics Inc. | -0.440% | 3.911% | 12.190% | -73.604% | -68.643% | -63.812% | -93.067% |
Comments
Genus (OTCMKTS:GENSF) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
Show more
Ratings data for GENSF provided by MarketBeat
